Studies of Phospholipid Reagents Used in Coagulation I: Some General Properties and Their Sensitivity to Factor VIII

Summary

Some general properties of phospholipid reagents have been studied, particularly in relation to their use in detection and measurement of Factor VIII deficiency. There was wide variation among reagents in their total phospholipid concentration, and in the degree of contamination with tissue factor and oxidation products. Although clotting times of normal and haemophilic plasma were affected by change of phospholipid concentration, presence of oxidation products, and order of addition of reagents, these factors did not appear to influence the efficiency of detection of the Factor VIII defect. The method of activation had a definite influence on sensitivity to Factor VIII deficiency, both the type of activator and the time of activation being important.

In Factor VIII one-stage assays, use of different phospholipids with the same substrate plasma gave significant differences in precision, but the estimates of potency of a Factor VIII concentrate against a plasma standard were not significantly different.

Keywords

Phospholipid - Factor VIII - APTT

• References

• 1 Bell WN, Alton HG A. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature 1954; 174: 880-881
• 2 Poller L, Thomson JM. The partial thromboplastin (cephalin) time test. J Clin Pathol 1972; 25: 1038-1044
• 3 Sibley CS, Singer JW, Wood RT. Comparison of activated partial thromboplastin reagents. Amer J Clin Pathol 1973; 59: 581-586
• 4 Hathaway WE, Assmus SL, Montgomery RR, Dubansky AS. Activated partial thromboplastin time and minor coagulopathies. Amer J Clin Pathol 1979; 71: 22-25
• 5 Hoffmann JJ M L, Meulendijk PN. Comparison of reagents for determining the activated partial thromboplastin time. Thromb Haemostas 1978; 39: 640-645
• 6 Poller L, Thomson JM, Palmer MK. Measuring partial thromboplastin time. An international collaborative study Lancet 1976; 1: 842-846
• 7 Barrowcliffe TW, Gray E. Studies of phospholipid reagents used in coagulation II: Factors influencing their sensitivity to heparin. Thromb Haemostas 1981; 46: 634-637
• 8 Barrowcliffe TW, Gray E. Factors affecting the sensitivity of the APTT to Factor VIII and heparin. Thromb Haemostas 1979; 42: 224 (abstr.)
• 9 Zucker S, Cathey MH, West B. Preparation of quality control specimes for coagulation. Amer J Clin Pathol 1970; 53: 924-927
• 10 Kates M. Techniques in lipidology. In Laboratory Techniques in Biochemistry and Molecular Bilogy. Ed Work and Work 1972; Vol. 3: 355-356
• 11 Malshet G, Tappel AL L. Fluorescent products of lipid peroxidation: I. Structural requirements for fluorescence in conjugated Schiff bases. Lipids 1973; 8: 194-198
• 12 Barrowcliffe TW, Stableforth PS, Dormandy KM. Small-scale preparation and clinical use of factor IX-prothrombin complex. Vox Sang 1973; 25: 426-441
• 13 Kirkwood TB L, Snape TJ. Biometric principles in clotting and clot lysis assays. Clin Lab Haematol 1980; 2: 155-167
• 14 Walsh PN, Lipscomb MS. Comparison of the coagulant activities of platelets and phospholipids. Br J Haematol 1976; 33: 9-18
• 15 Barrowcliffe TW, Gutteridge JM C, Dormandy TL. The effect of fatty acid autoxidation products on blood coagulation. Thromb Diathes Haemorrh 1975; 33: 271-277
• 16 Barrowcliffe TW, Kirkwood TB L. An international collaborative assay of Factor VIII clotting activity. Thromb Haemostas 1978; 40: 260-271
• 17 Kirkwood TB L, Rizza CR, Snape TJ, Rhymes IL, Austen DE G. Identification of sources of inter-laboratory variation in Factor VIII assay. Br J Haematol 1977; 37: 559-568
• 18 Barrowcliffe TW, Kirkwood TB L. Standardisation of Factor VIII. I: Calibration of British Standards for Factor VIII clotting activity. Br J Haematol 1980; 46: 471-481